Citius Pharmaceuticals Inc
F:47N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Citius Pharmaceuticals Inc
F:47N
|
US |
|
C
|
Cooper Companies Inc
F:CP6
|
US |
|
W
|
Workday Inc
XMUN:W7D
|
US |
|
Palo Alto Networks Inc
BMV:PANW
|
US |
Shareholder Yield
Current shareholder yield for 
47N is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
47N Price
Citius Pharmaceuticals Inc
| Average Annual Return | -25.06% |
| Standard Deviation of Annual Returns | 22.38% |
| Max Drawdown | -96% |
| Market Capitalization | 14.3m EUR |
| Shares Outstanding | 180 672 992 |
| Percentage of Shares Shorted |
N/A
|
47N Return Decomposition
Main factors of price return
Stock Splits
47N's latest stock split occurred on Nov 26, 2024
The company executed a 1-for-25 stock split, meaning that for every 25 shares held, investors received 1 new share.
Before the split, 47N traded at 0.1316 per share. Afterward, the share price was about 3.29.
The adjusted shares began trading on Nov 26, 2024. This was the only stock split in 47N's history.
